- Indianapolis IN, US Shao-Chun Chang - Carmel IN, US Yanzhi Hsu - Basking Ridge NJ, US Ling Yang - Bridgewater NJ, US
Assignee:
IMCLONE, LLC - Indianapolis IN
International Classification:
C07K 16/28 G01N 33/574
Abstract:
The invention provides for a human antibody that binds to human vascular endothelial growth factor receptor , preferably ramucirumab, for the treatment of hepatocellular carcinoma in patients having levels of alpha-fetoprotein (AFP) of 1.5 ULN or greater, and as a predictive method for the treatment of HCC in patients having AFP levels of ×ULN or greater.